CD8A and esophageal squamous cell carcinoma: Comprehensive immune characterization of the risk-stratified cohorts revealed significant enrichment of CD8+ T cells, dendritic cells (DCs), and plasmacytoid dendritic cells (pDCs) in high-risk ESCC patients relative to low-risk individuals (Figure 10A).